We are live on ! Find out more
RBOT

Vicarious Surgical

Delisted

RBOT was delisted on the 2nd of March, 2026.

36 hedge funds and large institutions have $4.58M invested in Vicarious Surgical in 2025 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

13% more funds holding

Funds holding: 3236 (+4)

1.23% more ownership

Funds ownership: 31.44%32.67% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

50% less capital invested

Capital invested by funds: $9.14M → $4.58M (-$4.56M)

Holders
36
Holders Change
+4
Holders Change %
+12.5%
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
10
Increased
7
Reduced
7
Closed
6
Calls
Puts
Net Calls
Net Calls Change

RBOT Hedge Fund Activity: Q4 2025 in Review

36 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q4 2025, worth a combined $4.58M — down 50% from $9.14M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new RBOT positions and 6 closed out — a net gain of 4 holders — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $2.46M. The largest seller was DDD Partners, exiting entirely with an estimated $1.03M sold.

  • 36 institutional investors held Vicarious Surgical (RBOT) as of Q4 2025, up from 32 in Q3 2025.
  • Funds reported $4.58M of Vicarious Surgical stock for Q4 2025, down 50% quarter-over-quarter.
  • 10 funds opened new Vicarious Surgical positions in Q4 2025 and 6 closed out, a net change of +4 holders.
  • The largest Vicarious Surgical buyer in Q4 2025 was Armistice Capital, an estimated $2.46M added.
  • The largest Vicarious Surgical seller in Q4 2025 was DDD Partners, an estimated $1.03M sold.

Based on aggregated 13F filings for Q4 2025.